Details for 2020884269

Up to date per 02.04.2026

Actions

Title / Product Name

VERFAHREN ZUR BEHANDLUNG UND/ODER PRÄVENTION VON SCHWERWIEGENDEN KARDIOVASKULÄREN EREIGNISSEN (MACE) MIT EINER KOMBINATION AUS EINEM BET-BROMDOMÄNENINHIBITOR UND EINEM NATRIUM-ABHÄNGIGEN GLUCOSETRANSPORT-2-INHIBITOR

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2020884269

EP Publication Number

4054584

E-Number

1811210

Language

PCT Number

IB20000912

Publication Date

14.09.2022 A

09.07.2025 B1

Registration Date

09.07.2025

AT Publication Date

15.07.2025

Application Date

04.11.2020

Registration Number

Priorities

05.11.2019

201962930860 P

IPC

A61K 31/517 20060101AFI20231005BHEP

Maximum Duration of Protection

04.11.2040

Owner

Resverlogix Corp.300, 4820 Richard Road SW Calgary, AB T3E 6L1CA

Representative

No representatives present

Inventor

LEBIODA, Kenneth Eugene216 Elbow Ridge Haven Calgary, AB T3Z 3T2CA

HALLIDAY, Christopher Ross Armstrong403 138 18 Avenue SE Calgary, AB T2G 5P9CA

KHAN, Aziz Naeem317 - 5115 Richard Road SW Calgary, AB T3E 7M7CA

Information about Fees